Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | ARG1 | P05089 | 4/20 | 0.40 |
| ▸ | DPP4 | P27487 | 2/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 2/20 | 0.34 |
| ▸ | NOS3 | P29474 | 1/20 | 0.34 |
| ▸ | NOS1 | P29475 | 1/20 | 0.34 |
| ▸ | ARG2 | P78540 | 1/20 | 0.33 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.33 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6515403 | 0.95 | MEN1 (0.42) | MEN1BLMKMT2ASLC1A2ARG1 | |
| Glycine SCHEMBL1675339 | 0.92 | MEN1 (0.41) | MEN1BLMKMT2ASLC1A2ARG1 | |
| Serine SCHEMBL5144903 | 0.86 | MEN1 (0.36) | MEN1BLMKMT2ASLC1A2ARG1 | |
| SCHEMBL4398036 | 0.84 | MEN1 (0.35) | MEN1BLMKMT2ASLC1A2ARG1 | |
| SCHEMBL6858329 | 0.77 | SLC1A2 (0.39) | MEN1BLMKMT2ASLC1A2ARG1 | |
| SCHEMBL3262655 | 0.77 | SLC1A2 (0.44) | MEN1BLMKMT2ASLC1A2ARG1 | |
| SCHEMBL2034433 | 0.77 | SLC1A2 (0.44) | MEN1BLMKMT2ASLC1A2ARG1 | |
| SCHEMBL22621401 | 0.75 | MEN1 (0.41) | MEN1BLMKMT2ASLC1A2ARG1 | |
| SCHEMBL2494402 | 0.75 | NOS2 (0.43) | MEN1BLMKMT2ADPP4DPP8 | |
| SCHEMBL678255 | 0.74 | SLC1A2 (0.48) | MEN1BLMKMT2ASLC1A2ARG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1596869-A4 | NOVEL COCRYSTALLIZATION | S S C I INC (US) | 2007-04-25 | — | — | EP | claimed |
| WO-2004064762-A9 | NOVEL COCRYSTALLIZATION | S S C I INC (US) | 2006-07-27 | — | — | WO | claimed |
| EP-1596869-A2 | NOVEL COCRYSTALLIZATION | S.S.C.I., Inc (US) | 2005-11-23 | — | — | EP | claimed |
| WO-2004064762-A2 | NOVEL COCRYSTALLIZATION | S.S.C.I. INC. (US) | 2004-08-05 | — | — | WO | claimed |
| CN-112823645-A | Dairy product and preparation method thereof | 内蒙古蒙牛乳业（集团）股份有限公司 | 2021-05-21 | — | — | CN | disclosed |
| CN-110192998-A | It is a kind of repair anti-aging composition and its application | 济南怡能食品科技有限公司 | 2019-09-03 | — | — | CN | disclosed |
| CN-110140844-A | A kind of beautifying and youth-keeping beverage and its preparation method and application | 济南怡能食品科技有限公司 | 2019-08-20 | — | — | CN | disclosed |
| EP-2975022-B1 | NOVEL HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | FUJIFILM TOYAMA CHEMICAL CO LTD (JP) | 2019-05-08 | — | — | EP | disclosed |
| CN-108796019-A | The method of extraction functionality dipeptides collagen from the gadus of the Arctic Ocean | 余碧芝 | 2018-11-13 | — | — | CN | disclosed |
| CN-105996059-A | Composition for increasing bone mineral density | 天津天狮生物发展有限公司 | 2016-10-12 | — | — | CN | disclosed |
| EP-2975022-A1 | NOVEL HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | Toyama Chemical Co., Ltd. (JP) | 2016-01-20 | — | — | EP | disclosed |
| US-20110058975-A1 | METHOD OF PROCESSING A BIMETALLIC PART | AEROJET ROCKETDYNE OF DE, INC. (F/K/A PRATT & WHITNEY ROCKETDYNE, INC.) | 2011-03-10 | — | — | US | disclosed |
| US-7767652-B2 | Medical devices and methods for reducing localized fibrosis | MEDTRONIC, INC. (US) | 2010-08-03 | — | — | US | disclosed |
| EP-1778310-A2 | MEDICAL DEVICES AND METHODS FOR REDUCING LOCALIZED FIBROSIS | Medtronic, Inc. (US) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006020231-A2 | MEDICAL DEVICES AND METHODS FOR REDUCING LOCALIZED FIBROSIS | MEDTRONIC, INC. (US) | 2006-02-23 | — | — | WO | disclosed |
| US-20060029636-A1 | Medical devices and methods for reducing localized fibrosis | MEDTRONIC, INC. (US) | 2006-02-09 | — | — | US | disclosed |
| WO-2004079345-A2 | MUSCULOSKELETAL ASSAY | UNIVERSITY COLLEGE LONDON (GB) | 2004-09-16 | — | — | WO | disclosed |
| WO-1997014795-A1 | TUMOR ASSOCIATED POLYPEPTIDES WITH CARBOXYL-TERMINAL ALANINE-PROLINE, PROLINE-PROLINE OR GLYCINE-PROLINE AND ANTIBODIES THERETO | JOHN WAYNE CANCER INSTITUTE (US) | 1997-04-24 | — | — | WO | disclosed |
| US-5571846-A | Method of inhibiting fibrosis | DUKE UNIVERSITY (US) | 1996-11-05 | — | — | US | disclosed |
| US-5374660-A | Asministering a benzoic hydrazide to treat antigrowth of fibroblasts, fibronectins, collagen | DUKE UNIVERSITY (US) | 1994-12-20 | — | — | US | disclosed |